EmileJFAblaOFraitagS. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages [published online March10, 2016]. Blood.
2.
RatzingerGBurgdorfWHMetzeDZelgerBGZelgerB. Indeterminate cell histiocytosis: fact or fiction?J Cutan Pathol. 2005;32(8):552-560.
ChomiczewskaDTrznadel-BudzkoEKaczorowskaARotsztejnH. The role of Langerhans cells in the skin immune system [in Polish]. Pol Merkur Lekarski. 2009;26(153):173-177.
5.
SteinmanRM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 1991;9:271-296.
6.
ZelgerBBurgdorfWH. The cutaneous “histiocytoses.”Adv Dermatol. 2001;17:77-114.
7.
VenerCSoligoDBertiE. Indeterminate cell histiocytosis in association with later occurrence of acute myeloblastic leukaemia. Br J Dermatol. 2007;156(6):1357-1361.
8.
SidoroffAZelgerBSteinerHSmithN. Indeterminate cell histiocytosis—a clinicopathological entity with features of both X- and non-X histiocytosis. Br J Dermatol. 1996;134(3):525-532.
9.
FoucarERosaiJDorfmanR. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol. 1990;7(1):19-73.
10.
FraterJLMaddoxJSObadiahJMHurleyMY. Cutaneous Rosai-Dorfman disease: comprehensive review of cases reported in the medical literature since 1990 and presentation of an illustrative case. J Cutan Med Surg. 2006;10(6):281-290.
WoodGSHuCHBecksteadJHTurnerRRWinkelmannRK. The indeterminate cell proliferative disorder: report of a case manifesting as an unusual cutaneous histiocytosis. J Dermatol Surg Oncol.1985;11(11):1111-1119.
13.
LogemannNThomasBYettoT. Indeterminate cell histiocytosis successfully treated with narrowband UVB. Dermatol Online J. 2013;19(10):20031.
14.
TothBKatonaMHarsingJSzepesiAKarpatiS. Indeterminate cell histiocytosis in a pediatric patient: successful treatment with thalidomide. Pathol Oncol Res. 2012;18(2):535-538.
15.
BardSTorchiaDConnellyEADuarteAMBadiavasEVSchachnerLA. S100-negative indeterminate cell histiocytosis in an African American child responsive to narrowband ultraviolet B. Pediatr Dermatol. 2011;28(5):524-527.
16.
GhanadanAKamyabKRamezaniM. Indeterminate cell histiocytosis: report of a case. Acta Medica Iranica. 2014;52(10):788-790.
17.
AmoYKawanoNTakasuHKatsuokaK. A case of solitary indeterminate cell histiocytosis. J Dermatol. 2003;30(10): 751-754.
18.
De PasqualeRLongoVPavoneAScuderiL. Cutaneous Rosai-Dorfman disease: a case report and a review of the literature. G Ital Dermatol Venereol. 2016;151(3):302-306.
KwinterJDeKovenJ. Generalized eruptive histiocytoma treated with isotretinoin. J Cutan Med Surg. 2009;13(3):146-150.
21.
Lan MaHMetzeDLugerTASteinhoffM. Successful treatment of generalized eruptive histiocytoma with PUVA. J Dtsch Dermatol Ges. 2007;5(2):131-134.
22.
PappoESchupbachAWorobecSM. Cutaneous Rosai-Dorfman disease: a case report. Dermatol Online J. 2012;18(11):6.
23.
VenturaFPereiraTda Luz DuarteMMarquesHPardalFBritoC. Indeterminate cell histiocytosis in association with acute myeloid leukemia. Dermatol Res Pract. 2010;2010:569345.
24.
YinRZhengWJYangXCHaoF. Recurrent generalized indeterminate cell histiocytosis: a case report. J Am Acad Dermatol. 2010;63(1):e3-5.
25.
BurnsMVAhmedACallahanGBLeLQCockerellC. Treatment of indeterminate cell histiocytosis with pravastatin. J Am Acad Dermatol. 2011;64(5):e85-e86.
26.
FournierJIngraffeaAPedvis-LeftickA. Successful treatment of indeterminate cell histiocytosis with low-dose methotrexate. J Dermatol. 2011;38(9):937-939.
